Welcome to ULS!
Welcome to ULS!
> Products > Research Areas > Neurological Disease
Products
Neurological Disease

Chemical structure

Cat.No.

Product Name

CAS no.

Target

  • YN483185 1,7-Dihydroxy-2,3-methylenedi... 183210-63-1

    1,7-Dihydroxy-2,3-methylenedioxyxanthone is isolated fromPolygala cyparissiaswhich is a small herb found in Brazil, Argentina and Uruguay.Polygala cyparissiasare used in folk medicine as an anaesthetic.

  • YN320988 AM251 183232-66-8

    AM251 block the inhibitory effects of endocannabinoids and synthetic cannabinoid agonists on transmitter release through an action at presynaptic cannabinoid 1 receptors in brain.

  • YN380308 β-Amyloid (35-42) 183292-41-3

    β-Amyloid (35-42) is a peptide consisting of amino acid of 35 to 42 of beta amyloid protein.

  • YN320131 CPPG 183364-82-1

    CPPG ((RS)-CPPG) is a potent group II/IIImGlu receptorsantagonist. CPPG exhibits some selectivity (approximately 20 fold) for group III (IC50=2.2nM) over group II (IC50=46.2nM) mGlu receptors in the rat cereb...

  • YN483696 D-Pentamannuronic acid 183668-50-0

    D-Pentamannuronic acid, an alginate oligomer, is produced by marine brown algae and by a limited range of Gram negative bacteria. D-Pentamannuronic acid can be used for the research of pain and vascular dementia.

  • YN483697 D-Hexamannuronic acid 183668-52-2

    D-Hexamannuronic acid, an alginate oligomer, is produced by marine brown algae and by a limited range of Gram negative bacteria. D-Hexamannuronic acid can be used for the research of pain and vascular dementia.

  • YN380283 β-Amyloid 1-15 183745-81-5

    β-Amyloid (1-15) is a fragment of β-Amyloid peptide. Beta-amyloid is a peptide that forms amyloid plaques in the brains of Alzheimer's disease (AD) patients.

  • YN320163 Abaperidone 183849-43-6

    Abaperidone is a potent antagonist of 5-HT2A receptor and dopamine D2receptor with IC50s of 6.2 and 17nM.

  • YN484149 Biotin-β-Amyloid (1-40) 183906-14-1

    Biotin-β-Amyloid (1-40) is a N-terminal-labelled biotinylated amyloid-ß-(1-40) peptide.

  • YN320893 Ciproxifan 184025-18-1

    Ciproxifan (FUB 359) is a potent, selective, orally bioavailable and competitive antagonist ofhistamine H3-receptor, with an IC50 of 9.2nM. Ciproxifan displays low apparent affinity at other receptor subtypes. Ciproxifan can be ...

  • YN320960 Ciproxifan maleate 184025-19-2

    Ciproxifan is a highly potent and selective histamin H3-receptor antagonist with IC50 of 9.2 nM, with low apparent affinity at other receptor subtypes.

  • YN484259 Carabersat 184653-84-7

    Carabersat is a potent anticonvulsant agent.

  • YN483222 Anhydrosafflor yellow B 184840-84-4

    Anhydrosafflor yellow B (AHSYB) is a quinochalcone C-glycoside isolated fromCarthamus tinctorius. Anhydrosafflor yellow B inhibits ADP-induced platelet aggregation, exhibits significant anti-oxidative effects in vitro, and p...

  • YN380298 β-Amyloid (29-40) 184865-04-1

    β-Amyloid (29-40) is a fragment of Amyloid-β peptide.

  • YN1730047 MRS-1191 185222-90-6

    MRS-1191 is a potent and selectiveA3adenosine receptorantagonist with aKBvalue of 92nM, aKivalue of 31.4nM for humanA3receptor and an IC50 of 120nM for CHO cells.

  • YN480336 Arundic Acid 185517-21-9

    Arundic acid (ONO-2506) is an astrocyte-modulating agent, which delays the expansion of cerebral infarcts by modulating the activation of astrocytes through inhibition of S-100β synthesis. Arundic acid has the potential for stroke a...

  • YN380092 (S)-Rasagiline 185517-74-2

    (S)-Rasagiline (TVP1022) is the S-isomer of Rasagiline, which is an anti-Parkinson drug, appears to have the same neuroprotective activity as the R-isomer, but is 1000-fold less active as an MAO-B inhibitor.

  • YN320536 BMS-193885 186185-03-5

    BMS-193885 is a potent, selective, competitive, and brain penetrantneuropeptide Y1receptorantagonist with a Ki of 3.3nM, and has an IC50 of 5.9nM for hY1, which displays > 100, > 160, > 160 and > 160-fold selectivity over α...

  • YN372996 Lurasidone Metabolite 14283 ... 186204-32-0

    Lurasidone Metabolite 14283 hydrochloride is a major active metabolite of Lurasidone. Lurasidone is a FDA approved drug for the treatment of schizophrenia.

  • YN372997 Lurasidone metabolite 14326 186204-33-1

    Lurasidone metabolite 14326 is an active metabolite of the atypical antipsychotic Lurasidone.

    Contact

    TELL : +86-020-82000279

    Email: sales@ubiochem.com

    Add:Room 519, Block F, Guangzhou International Business Incubator, No.3 Lanyue Road, Science Town, Huangpu District, Guangzhou, China.

ULS products are chemical reagents for Research Use Only!Copyright © 2020-2021 ULS. All Rights Reserved.备案号:粤ICP备2021013238号-2
3.817808s